Tactile Systems Technology (TCMD) Cash from Financing Activities (2015 - 2026)
Tactile Systems Technology's (TCMD) quarterly Cash from Financing Activities came in at -$1.1 million in Q1 2026, up 90.21% year-on-year from -$553593.0 in Q1 2025, and down 238.19% on a QoQ basis from $762000.0 in Q4 2025.
Tactile Systems Technology (TCMD) Cash from Financing Activities (2015 - 2026) Analysis & Trends
Tactile Systems Technology (TCMD) has 12 years of Cash from Financing Activities data on file, last reported at -$1.1 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 90.21% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was -$41.5 million, a 179.73% decrease from a year earlier, with the FY2025 full-year figure at -$51.2 million, down 961.3% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$1.1 million, down from $762000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for TCMD reached as high as $33.9 million in Q1 2023 and fell as low as -$24.8 million in Q3 2025.
- Historically, Cash from Financing Activities has averaged -$3.6 million across 5 years, with a median of -$1.1 million in 2026.
- Across the five-year window, Cash from Financing Activities jumped 1016.04% in 2023 and slumped 5676.61% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at -$5.3 million in 2022, then tumbled by 323.96% to -$22.4 million in 2023, then surged by 83.85% to -$3.6 million in 2024, then jumped by 121.05% to $762000.0 in 2025, then tumbled by 238.19% to -$1.1 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$1.1 million in Q1 2026, $762000.0 in Q4 2025, and -$24.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tactile Systems Technology | 619.08 Mn | 528.88 Mn | 57.61 Mn | -1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.05 Mn |
| Mar 31, 2026 | -1.05 Mn |
| Dec 31, 2025 | 762,000.00 |
| Dec 31, 2025 | 762,000.00 |
| Sep 30, 2025 | -24.75 Mn |
| Sep 30, 2025 | -24.75 Mn |
| Jun 30, 2025 | -16.45 Mn |
| Jun 30, 2025 | -16.45 Mn |
| Mar 31, 2025 | -10.76 Mn |
| Mar 31, 2025 | -10.76 Mn |
| Dec 31, 2024 | -3.62 Mn |
| Dec 31, 2024 | -3.62 Mn |
| Sep 30, 2024 | -750,000.00 |
| Sep 30, 2024 | -750,000.00 |
| Jun 30, 2024 | 295,000.00 |
| Jun 30, 2024 | 295,000.00 |
| Mar 31, 2024 | -749,000.00 |
| Mar 31, 2024 | -749,000.00 |
| Dec 31, 2023 | -22.42 Mn |
| Dec 31, 2023 | -22.42 Mn |